426 related articles for article (PubMed ID: 19127133)
1. Cost-effectiveness of dalteparin versus unfractionated heparin as venous thromboembolism prophylaxis in malignant gynecologic surgery.
Wade WE; Spruill WJ
Am J Ther; 2008; 15(6):512-5. PubMed ID: 19127133
[TBL] [Abstract][Full Text] [Related]
2. Extended dalteparin prophylaxis for venous thromboembolic events: cost-utility analysis in patients undergoing major orthopedic surgery.
Dranitsaris G; Stumpo C; Smith R; Bartle W
Am J Cardiovasc Drugs; 2009; 9(1):45-58. PubMed ID: 19178131
[TBL] [Abstract][Full Text] [Related]
3. Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
DeBernardo RL; Perkins RB; Littell RD; Krasner CN; Duska LR
Obstet Gynecol; 2005 May; 105(5 Pt 1):1006-11. PubMed ID: 15863537
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients.
Fowler RA; Mittmann N; Geerts W; Heels-Ansdell D; Gould MK; Guyatt G; Krahn M; Finfer S; Pinto R; Chan B; Ormanidhi O; Arabi Y; Qushmaq I; Rocha MG; Dodek P; McIntyre L; Hall R; Ferguson ND; Mehta S; Marshall JC; Doig CJ; Muscedere J; Jacka MJ; Klinger JR; Vlahakis N; Orford N; Seppelt I; Skrobik YK; Sud S; Cade JF; Cooper J; Cook D; ;
JAMA; 2014 Nov; 312(20):2135-45. PubMed ID: 25362228
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial.
Fowler RA; Mittmann N; Geerts WH; Heels-Ansdell D; Gould MK; Guyatt G; Krahn M; Finfer S; Pinto R; Chan B; Ormanidhi O; Arabi Y; Qushmaq I; Rocha MG; Dodek P; McIntyre L; Hall R; Ferguson ND; Mehta S; Marshall JC; Doig CJ; Muscedere J; Jacka MJ; Klinger JR; Vlahakis N; Orford N; Seppelt I; Skrobik YK; Sud S; Cade JF; Cooper J; Cook D; ;
Trials; 2014 Dec; 15():502. PubMed ID: 25528663
[TBL] [Abstract][Full Text] [Related]
6. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients.
McGarry LJ; Thompson D; Weinstein MC; Goldhaber SZ
Am J Manag Care; 2004 Sep; 10(9):632-42. PubMed ID: 15515996
[TBL] [Abstract][Full Text] [Related]
8. Thromboembolic prophylaxis in moderate-risk patients undergoing elective abdominal surgery: decision and cost-effectiveness analyses.
Mamdani MM; Weingarten CM; Stevenson JG
Pharmacotherapy; 1996; 16(6):1111-27. PubMed ID: 8947985
[TBL] [Abstract][Full Text] [Related]
9. Prevention of venous thromboembolic events after gynecologic surgery.
Clarke-Pearson DL; Abaid LN
Obstet Gynecol; 2012 Jan; 119(1):155-67. PubMed ID: 22183223
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cost, effectiveness, and safety of injectable anticoagulants used for thromboprophylaxis after orthopedic surgery.
Shorr AF; Sarnes MW; Peeples PJ; Stanford RH; Happe LE; Farrelly E
Am J Health Syst Pharm; 2007 Nov; 64(22):2349-55. PubMed ID: 17989444
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgery.
Dainty L; Maxwell GL; Clarke-Pearson DL; Myers ER
Gynecol Oncol; 2004 May; 93(2):366-73. PubMed ID: 15099947
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of prolonged thromboprophylaxis after cancer surgery.
Bradley CT; Brasel KJ; Miller JJ; Pappas SG
Ann Surg Oncol; 2010 Jan; 17(1):31-9. PubMed ID: 19707830
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical follow-up in 265 patients with deep venous thrombosis initially treated with either unfractionated heparin or dalteparin: a retrospective analysis.
Holmström M; Aberg W; Lockner D; Paul C
Thromb Haemost; 1999 Oct; 82(4):1222-6. PubMed ID: 10544902
[TBL] [Abstract][Full Text] [Related]
15. Perioperative venous thromboembolism in patients with gynecological malignancies: a lesson from four years of recent clinical experience.
Morimoto A; Ueda Y; Yokoi T; Tokizawa Y; Yoshino K; Fujita M; Kimura T; Kobayashi E; Matsuzaki S; Egawa-Takata T; Sawada K; Tsutsui T; Kimura T
Anticancer Res; 2014 Jul; 34(7):3589-95. PubMed ID: 24982374
[TBL] [Abstract][Full Text] [Related]
16. Dalteparin versus enoxaparin for venous thromboembolism prophylaxis in acute spinal cord injury and major orthopedic trauma patients: 'DETECT' trial.
Slavik RS; Chan E; Gorman SK; de Lemos J; Chittock D; Simons RK; Wing PC; Ho SG
J Trauma; 2007 May; 62(5):1075-81; discussion 1081. PubMed ID: 17495705
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of rivaroxaban versus heparins for prevention of venous thromboembolism after total hip or knee surgery in Sweden.
Ryttberg L; Diamantopoulos A; Forster F; Lees M; Fraschke A; Björholt I
Expert Rev Pharmacoecon Outcomes Res; 2011 Oct; 11(5):601-15. PubMed ID: 21958104
[TBL] [Abstract][Full Text] [Related]
18. Extended thromboprophylaxis reduces incidence of postoperative venous thromboembolism in laparoscopic bariatric surgery.
Magee CJ; Barry J; Javed S; Macadam R; Kerrigan D
Surg Obes Relat Dis; 2010; 6(3):322-5. PubMed ID: 20510295
[TBL] [Abstract][Full Text] [Related]
19. Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective.
Hull RD; Raskob GE; Rosenbloom D; Pineo GF; Lerner RG; Gafni A; Trowbridge AA; Elliott CG; Green D; Feinglass J
Arch Intern Med; 1997 Feb; 157(3):289-94. PubMed ID: 9040295
[TBL] [Abstract][Full Text] [Related]
20. [Prevention of venous thromboembolism in internal medicine and neurology].
Malý J; Dulícek P; Penka M; Malý R; Gumulec J
Vnitr Lek; 2006 Mar; 52 Suppl 1():63-7. PubMed ID: 16637452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
